Study of Biologics for Severe Asthma in Hong Kong
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study looks at how biologic medicines (special injections or infusions) are used to treat severe asthma in Hong Kong. It may help researchers understand why some people stop or switch these treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of severe asthma (as defined by standard international guidelines).
- You must have received at least one dose of a biologic medicine for your asthma.
- You cannot have other serious lung diseases such as tuberculosis-damaged lungs, a history of lung removal surgery, or lung cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from adults with severe asthma to better understand the condition and improve treatment. Your participation involves sharing medical data to help researchers learn more about what works best for severe asthma.
This study looks at how genes are linked to different types and severities of asthma. It aims to understand why asthma affects people differently, which could lead to better treatments.
This study is creating a registry to track the long-term safety and effectiveness of biologic treatments for severe asthma in Taiwan. If you are taking a biologic like omalizumab, mepolizumab, or benralizumab, joining this registry helps doctors learn how well these medicines work over time.
This trial looks at people with severe asthma that is hard to control. It aims to find and treat specific health problems that make asthma worse, by doing a detailed check-up and using treatments that are right for you.
This study tests if a personalized exercise program can help adults with severe asthma who are starting a new biologic treatment. It aims to improve symptoms and quality of life.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.